|Year : 2020 | Volume
| Issue : 7 | Page : 1446-1447
Acquired retinal astrocytoma: Transpupillary thermotherapy may be a viable alternative treatment option
Devashish Dubey, Rajesh Ramanjulu, Mahesh P Shanmugam, Divyansh K Mishra
Sankara Eye Hospital, Kundalahalli, Bangalore, Karnataka, India
|Date of Submission||18-Sep-2019|
|Date of Acceptance||20-Feb-2020|
|Date of Web Publication||25-Jun-2020|
Dr. Rajesh Ramanjulu
Sankara Eye Hospital, Varthur Road, Kundalahalli, Bangalore - 560 037, Karnataka
Source of Support: None, Conflict of Interest: None
Keywords: Acquired retinal astrocytoma, glial proliferation, retinal glial tumors, transpupillary thermotherapy
|How to cite this article:|
Dubey D, Ramanjulu R, Shanmugam MP, Mishra DK. Acquired retinal astrocytoma: Transpupillary thermotherapy may be a viable alternative treatment option. Indian J Ophthalmol 2020;68:1446-7
|How to cite this URL:|
Dubey D, Ramanjulu R, Shanmugam MP, Mishra DK. Acquired retinal astrocytoma: Transpupillary thermotherapy may be a viable alternative treatment option. Indian J Ophthalmol [serial online] 2020 [cited 2020 Jul 14];68:1446-7. Available from: http://www.ijo.in/text.asp?2020/68/7/1446/287515
A 14-year-old boy was referred with complaints of diminution of vision in the right eye for the past 1 year. He had no known systemic illness or family history of genetic disorders. His best-corrected visual acuity (BCVA) in the right eye was 20/200, N36 while the left eye was 20/20, N6. The anterior segment was unremarkable. The right eye fundus examination revealed an amelanotic juxta-papillary mass with surrounding exudation [Figure 1]a. Aided by SS-OCT [Figure 1]b and FFA [Figure 2] findings a diagnosis of presumed acquired retinal astrocytoma (ARA) was made and the lesion was treated with photodynamic therapy. Minimal reduction in exudation without alteration in the lesion size was noted at 6-month follow-up. As an alternative to standard therapy, transpupillary thermotherapy (TTT) was done for the patient. A 100 mW power, for 3 minutes was applied, with 3 mm spot size, delivering 17 mJ of total energy. A significant reduction in the lesion size with a resolution of hard exudates at the macula and one-line improvement in visual acuity on the early treatment diabetic retinopathy study (ETDRS) chart was noted 2 months after TTT [Figure 3] and [Figure 4].
|Figure 1: Fundus picture showing a juxtapapillary yellow-white mass lesion 4.5 × 6 mm in size with surrounding intra and subretinal exudation (a). Optical coherence tomography picture showing presence of a hyperreflective non calcified mass lesion arising from inner retinal layers with back shadowing (b)|
Click here to view
|Figure 2: Fluorescein angiography image showing the presence of fine branching vascularity of the mass with minimal hyper fluorescence in the early phase (a), the fluorescence increases through transit with profuse leakage in the late phase (b)|
Click here to view
|Figure 3: Image showing the tumor response to the course of treatment. Fundus picture showing the appearance of the tumor at presentation (a). 6 months post Photodynamic therapy fundus image showing minimal reduction of exudates over macula without any significant reduction in tumor size, with presence of preretinal haemorrhage (b). 2 month after Transpupillary thermotherapy fundus image showing a significant reduction in size of mass lesion with near-complete resolution of exudation over macula and papillomacular bundle (c)|
Click here to view
|Figure 4: Comparison Optical coherence tomography images showing the tumor height 6 months after photodynamic therapy (a) and a significant reduction in its size after 2 months of transpupillary thermotherapy (b)|
Click here to view
| Discussion|| |
ARA is a benign intraocular glial tumor, having no association with tuberous sclerosis. It is typically juxta-papillary or macular in location. Unlike retinal astrocytic hamartoma (RAH), it lacks calcification and exhibits progressive growth.,
Current treatment modalities for ARA include photodynamic therapy (PDT), laser photocoagulation, and plaque radiotherapy. Mennel et al. and Shields et al., first described the use of PDT for RAH and ARA, respectively.,
Effectiveness of TTT to our knowledge has not been described in cases of ARA. We believe TTT has a dual mode of action. First, it causes thermal cytotoxic damage leading to cell apoptosis. Second, it causes heat-induced sclerosis of the vascular channels causing tumor regression and resolution of exudation.
This photo essay highlights the typical findings in a case of ARA and also reports a yet undescribed treatment modality in such cases.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Shields CL, Shields JA, Eagle Jr RC, Cangemi F. Progressive enlargement of acquired retinal astrocytoma in 2 cases. Ophthalmology 2004;111:363-8.
Shields JA, Shields CL. Intraocular Tumors: A Text and Atlas. WB Saunders Company; 2006.
Mennel S, Meyer CH, Peter S, Schmidt JC, Kroll P. Current treatment modalities for exudative retinal hamartomas secondary to tuberous sclerosis: Review of the literature. Acta Ophthalmol Scand 2007;85:127-32.
Shields CL, Materin MA, Marr BP, Krepostman J, Shields JA. Resolution of exudative retinal detachment from retinal astrocytoma following photodynamic therapy. Arch Ophthalmol 2008;126:273-4.
Ip M, Kroll A, Reichel E. Transpupillary thermotherapy. Semin Ophthalmol 1999;14:11-8. Taylor & Francis.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]